<DOC>
	<DOCNO>NCT00706121</DOCNO>
	<brief_summary>RATIONALE : Studying tissue sample laboratory participant receive treatment Selenium Vitamin E Cancer Prevention Trial ( SELECT ) SWOG-S0000 may help doctor predict participant 's response treatment help plan best treatment . PURPOSE : This phase III trial study effect vitamin E and/or selenium colorectal polyp men enrol SELECT Trial SWOG-S0000 .</brief_summary>
	<brief_title>S0000D : Effect Vitamin E and/or Selenium Colorectal Polyps Men Enrolled SELECT Trial SWOG-S0000</brief_title>
	<detailed_description>OBJECTIVES : Primary - To assess effect selenium colorectal adenoma ( CRA ) occurrence . - To assess effect selenium number , location , size , histologic type , degree dysplasia CRA . - To assess effect selenium colorectal cancer ( CRC ) incidence . Secondary - To assess effect vitamin E CRA occurrence . - To assess effect vitamin E CRC incidence . Tertiary - To explore effect modification selenium vitamin E aspirin CRA occurrence . - To explore effect modification selenium vitamin E body mass index . OUTLINE : This multicenter study . Endoscopically obtained tissue sample review study pathologist confirm presence ( absence ) colorectal adenoma ( CRA ) . If CRA present , number , location , size , histology , degree dysplasia document . The CRA also review exclude diagnosis colorectal cancer . Additional data , include aspirin use , height weight , date birth , demographic baseline characteristic , also obtain . Participants ' medical record review periodically . Participants follow annually .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Enrolled Selenium Vitamin E Cancer Prevention Trial ( SELECT ) SWOGS0000 Screened low endoscopy ( i.e. , sigmoidoscopy and/or colonoscopy ) randomization SELECT trial PATIENT CHARACTERISTICS : Willing sign applicable medical record release form Willing allow release tissue central pathology review resect polyps endoscopic biopsy PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>colon cancer</keyword>
	<keyword>rectal cancer</keyword>
	<keyword>adenomatous polyp</keyword>
</DOC>